Ocular Therapeutix

company

About

Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2006
Number Of Employee
51 - 100
Operating Status
Active

Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$64.80M
Ocular Therapeutix has raised a total of $64.80M in funding over 2 rounds. Their latest funding was raised on Jun 10, 2013 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 10, 2013 Series D $23.80M 1 Detail
Feb 3, 2011 Series D $14M 1 Detail
Jan 12, 2011 Series C $6M 1 Detail
Jun 24, 2009 Series C $15M 1 Detail
Mar 7, 2008 Series B $6M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Ocular Therapeutix is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series D